- The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation for GSK's blood cancer drug Blenrep. (Reporting.
- The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation for GSK's blood cancer drug Blenrep. (ReportingWe have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: